Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years because of the United States' request for confidential information.
This move was revealed after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson later explained that the US was requesting health data for research and commercial gain but was not willing to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more negotiations to reach a deal agreeable to both sides so the country's critical HIV treatment initiative can continue.
Broader Background
This development comes after a similar situation in Kenya, where a high court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to boost openness and responsibility.
According to statements, Sixteen nations in Africa have to date signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"In essence, our country would supply the basic resources for medical research with no certainty that the final treatments would be available to our citizens if a future pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its push of bilateral deals were upending frameworks already established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This mechanism is intended to ensure that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We encourage continued discussions with our American counterparts on how subsequent collaboration could be arranged in a way that respects the independence and dignity of each country."
Medical Community Response
Medical experts expressed it acknowledged the government's concerns, but suggested that negotiations should continue since much of the country's Aids initiatives were funded by international support.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.
The situation underscores the ongoing tensions between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.